The big news today is Daiichi Sankyo's acquisition of a controlling stake in Ranbaxy, India's largest pharmaceutical company, for $4.6bn. Analysts have been quick to predict many more such deals which will see international pharma majors entering the generic space....
If you use an RSS reader, you can subscribe to a feed of all future entries tagged 'Ranbaxy'. [What is this?]